LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Barasertib | 0.04 | uM | LJP5 | 72 | hr | 1311 | 1941 | 5079 | 0.3823 | 0.2224 |
MDA-MB-231 | Barasertib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 1628 | 5079 | 0.3207 | 0.1165 |
MDA-MB-231 | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 1670 | 5079 | 0.3290 | 0.1319 |
MDA-MB-231 | Barasertib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 1656 | 5079 | 0.3261 | 0.1267 |
MDA-MB-231 | Barasertib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1607 | 5079 | 0.3164 | 0.1089 |
MDA-MB-231 | Barasertib | 10 | uM | LJP5 | 72 | hr | 1311 | 1507 | 5079 | 0.2967 | 0.0735 |
MDA-MB-231 | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 1311 | 4847 | 5079 | 0.9542 | 0.9525 |
MDA-MB-231 | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4839 | 5079 | 0.9528 | 0.9511 |
MDA-MB-231 | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4824 | 5079 | 0.9493 | 0.9463 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4731 | 5079 | 0.9314 | 0.9283 |
MDA-MB-231 | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4060 | 5079 | 0.7992 | 0.7829 |
MDA-MB-231 | Vemurafenib | 10 | uM | LJP5 | 72 | hr | 1311 | 2744 | 5079 | 0.5403 | 0.4591 |
MDA-MB-231 | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 1311 | 4962 | 5079 | 0.9771 | 0.9760 |
MDA-MB-231 | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4986 | 5079 | 0.9817 | 0.9809 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4838 | 5079 | 0.9521 | 0.9494 |
MDA-MB-231 | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4705 | 5079 | 0.9265 | 0.9230 |
MDA-MB-231 | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4917 | 5079 | 0.9678 | 0.9666 |
MDA-MB-231 | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 1311 | 5142 | 5079 | 1.0125 | 1.0128 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 1311 | 3634 | 4935 | 0.7362 | 0.7031 |
MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 1311 | 3289 | 4935 | 0.6665 | 0.6175 |
MDA-MB-231 | Palbociclib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 2996 | 4935 | 0.6069 | 0.5393 |
MDA-MB-231 | Palbociclib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 2692 | 4935 | 0.5454 | 0.4563 |
MDA-MB-231 | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 2426 | 4935 | 0.4915 | 0.3792 |
MDA-MB-231 | Palbociclib | 10 | uM | LJP6 | 72 | hr | 1311 | 2153 | 4935 | 0.4363 | 0.2959 |
MDA-MB-231 | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 1311 | 4542 | 4935 | 0.9203 | 0.9150 |